September - 2020
| Previous Next | Showing Journal 5 of 7 |
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 - The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialThe Writing Committee for the REMAP-CAP Investigators JAMA, 2020, online Sept 2020 |
September |
Previous Comments
No Comments yet.
Comment
This is an important trial for a number of reasons. Firstly, it reports the effect of hydrocortisone in COVI-19. Secondly, it is the first publication from REMAP-CAP, an adaptive Bayesian platform trial
In July the RECOVERY trial reported
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register